Follow the entities shaping the evidence.

…NfL was higher in all neuropathy groups versus HC (all p<0.01). Periaxin was elevated in two out of eight CMT2A patients, two out of eig…

…y different specialties. Multiple organ systems are affected by eating disorders, which then requires an integration of care to adequately treat…

… have sex with men (GBMSM) and national data on UK-acquired new HIV diagnoses categorised by ethnicity and probable HIV exposure ro…

… solid tumors and aimed to define the recommended Phase 2 dose. AgenT-797 was administered as a single intravenous infusion using a 3+3 d…

… with treatment-naïve, stage IV NSQ NSCLC without AGAs received STK-012 subcutaneously (SC) Q3W + standard of care pembrolizumab, pemet…

…Foundation for Cancer Research.References Ritter J, Bielack SS. Osteosarcoma. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2010;21(Suppl 7):vii…

…ensi E, Leonard-Louis S, Allenbach, Y. Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multic…

…cines. 2023;11(2):508.Liu C, Huang Y, Cui Z, et al. KRAS-mutant non-small cell lung cancer: from molecular heterogeneity to clinical management. Cancer Co…

…sociated with improved clinical response (p=0.0224).Conclusions PDS01ADC treatment increases peripheral NK cells with specific phenotype…

… S, Wong A, Yong WP, Soo RA, Chee CE, Tan DS. 458MO Efficacy of durvalumab (Durva) in combination with olaparib (Ola) and capivasertib (Ca…

…CT06197672Ethics Approval The study obtained ethics approval by Indiana University and University of Miami IRB and participants gave informed cons…

…ncer that have a poor prognosis with limited treatment options. Tarlatamab is a first-in-class, half-life extended delta-like ligand 3 (DL…